Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × Advanced Cancer × Ifosfamide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Chemotherapeutic Agent Toxicity 1 Advanced Cancer 1

Interventions

Ifosfamide 1 Amblyomin-X protein, Amblyomma cajennense 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00607711 2008-05-05

Study of Oral Palifosfamide Tris in Solid Tumors

Alaunos Therapeutics

Phase 1 Suspended

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡